Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00664300
Other study ID # CHU-0032
Secondary ID RBHP 2007 Jalenq
Status Completed
Phase N/A
First received April 21, 2008
Last updated January 18, 2011
Start date August 2007
Est. completion date October 2009

Study information

Verified date January 2011
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

Gilles de la Tourette's syndrome is a childhood onset inherited neuropsychiatric disorder characterised by the presence of both multiple motor tics and one or more vocal tics (noises), with psychiatric and/or behaviour disorders (such as obsessive compulsive behaviour…).

This disease is associated with an dopamine system imbalance which could be responsible of a specific trouble in the recognition in some facial expression. This has been already shown in Gilles de la Tourette patients with obsessive compulsive behaviour.

We hypothesise that patients with Gilles de la Tourette's syndrome present a dysfunction of voluntary and automatic treatment of emotional information.

The main purpose of this study is to show if patients with Gilles de la Tourette's syndrome present a lack of specific facial expression recognition of emotion and determinate more precisely if this alteration involves the cortical way (high frequency way) or the under cortical way (low frequency way).


Description:

20 patients with Gilles de la Tourette's syndrome compared to 20 healthy paired volunteers.

Study progress (patients):

Inclusion visit :

Psychiatric evaluation Psychological evaluation

Ophthalmic visit

Protocol :

Facial expression recognition test Lexical decision test

Study progress (healthy volunteers):

Psychiatric evaluation Ophthalmic visit Facial expression recognition test Lexical decision test


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 2009
Est. primary completion date October 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age : >18 years

- Patient with a Gilles de la Tourette 's syndrome such as defined in the DSMIV

- Stability of treatment >1 month

- Mini Mental State > 26

- Affiliation to social security

- Agreement of patients

Exclusion Criteria:

- Patients with cognitive disorders, dementia, mental retardation…

- Patients with serious neurological pathologies

- Patients with a vision contrast altered.

- Patients who do not understand the words associated with an emotion

- Pregnant women

- Person who participate to an other study

Study Design

N/A


Intervention

Behavioral:
Facial expression recognition of emotion
Facial expression recognition test Lexical decision test

Locations

Country Name City State
France CHU Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Facial expression recognition test % of exact responses Yes
Secondary Lexical decision test The time to respond Yes
See also
  Status Clinical Trial Phase
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A